Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple blood test could revolutionize Alzheimer's diagnosis

NCT ID NCT04850053

Recruiting now Diagnosis Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new blood test called the AD-seeds-detector that looks for specific protein clumps linked to Alzheimer's disease. Researchers will compare the test results from 1,500 people aged 55-75, including those with Alzheimer's, other dementias, and healthy individuals. The goal is to see if this test can diagnose Alzheimer's more accurately than current methods.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AD-seeds-detector (blood test device)
What this could lead to
If successful, this could lead to a simple blood test that helps doctors diagnose Alzheimer's disease more accurately and earlier.
What could go wrong
This is an early-stage diagnostic study, not a treatment. The test may not be accurate enough or may not work for all types of dementia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease behavioral variant of frontotemporal dementia corticobasal degeneration disorder inherited Creutzfeldt-Jakob disease Lewy body dementia progressive non-fluent aphasia semantic dementia vascular dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE

Contacts and locations

Locations

  • Xuanwu Hospital of Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 100053, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.